Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 16, 2022

SELL
$4.63 - $9.94 $64,820 - $139,160
-14,000 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$8.35 - $12.6 $223,780 - $337,680
-26,800 Reduced 65.69%
14,000 $128,000
Q3 2021

Nov 15, 2021

BUY
$10.13 - $15.0 $113,456 - $168,000
11,200 Added 37.84%
40,800 $436,000
Q2 2021

Aug 16, 2021

BUY
$13.27 - $18.48 $383,503 - $534,072
28,900 Added 4128.57%
29,600 $459,000
Q1 2021

May 17, 2021

BUY
$14.49 - $20.72 $10,143 - $14,504
700 New
700 $11,000

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $227M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.